Butanone

Butanone

SCHEMBL11122

CCC(C)=O.Cc1noc(-c2ccc(Br)cc2)c1N

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1F O60840 1/20 0.40
ABCB1 P08183 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40
RAB9A P51151 5/20 0.39
NPC1 O15118 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
ALDH1A1 P00352 4/20 0.39
TP53 P04637 2/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.38
KDM4E B2RXH2 2/20 0.37
POLB P06746 2/20 0.37
PKM P14618 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
PTPN1 P18031 1/20 0.36
MAPT P10636 2/20 0.36
TARBP2 Q15633 1/20 0.36
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1223 0.87 MEN1 (0.39) RAB9ANPC1SMN1; SMN2ALDH1A1HTT
Cyclohexanone SCHEMBL6726 0.77 TRPV1 (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL2290795 0.73 LPAR1 (0.52) HTT
SCHEMBL13426 0.73 LMNA (0.42) CACNA1FABCB1CACNA1DCACNA1SCACNA1C
SCHEMBL4233 0.73 BACE1 (0.44) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL8243211 0.72 ALDH1A1 (0.64) CACNA1FABCB1CACNA1DCACNA1SCACNA1C
SCHEMBL3744 0.72 ALDH1A1 (0.45) RAB9ANPC1SMN1; SMN2ALDH1A1HTT
SCHEMBL11123 0.72 LPAR1 (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL1476 0.72 LPAR1 (0.43) RAB9ASMN1; SMN2ALDH1A1KDM4EBRD4
SCHEMBL14789798 0.72 RAB9A (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed